Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.

Authors :: Otsuka T
Shirakawa T
Shimokawa M
Koga F
Kawaguchi Y
Ueda Y
Nakazawa J
Komori A
Otsu S
Arima S
Fukahori M
Okabe Y
Makiyama A
Taguchi H
Honda T
Shibuki T
Nio K
Ide Y
Mizuta T
Mitsugi K
Ureshino N
Source :: International journal of clinical oncology [Int J Clin Oncol] 2021 May; Vol. 26 (5), pp. 951-953.
Publication Year :: 2021

Full Text Access

Tools